Incidence and Etiology of Drug-Induced Liver Injury in Mainland China.

BACKGROUND & AIMS We performed a nationwide, retrospective study to determine the incidence and causes of drug-induced liver injury (DILI) in mainland China. METHODS We collected data on a total of 25,927 confirmed DILI cases, hospitalized from 2012 through 2014 at 308 medical centers in mainland China. We collected demographic, medical history, treatment, laboratory, disease severity, and mortality data from all patients. Investigators at each site were asked to complete causality assessments for each case whose diagnosis at discharge was DILI (n = 29,478) according to the Roussel Uclaf Causality Assessment Method. RESULTS Most cases of DILI presented with hepatocellular injury (51.39%; 95% confidence interval [CI] 50.76-52.03), followed by mixed injury (28.30%; 95% CI 27.73-28.87) and cholestatic injury (20.31%; 95% CI 19.80-20.82). The leading single classes of implicated drugs were traditional Chinese medicines or herbal and dietary supplements (26.81%) and antituberculosis medications (21.99%). Chronic DILI occurred in 13.00% of the cases and, although 44.40% of the hepatocellular DILI cases fulfilled Hy's Law criteria, only 280 cases (1.08%) progressed to hepatic failure, 2 cases underwent liver transplantation (0.01%), and 102 patients died (0.39%). Among deaths, DILI was judged to have a primary role in 72 (70.59%), a contributory role in 21 (20.59%), and no role in 9 (8.82%). Assuming the proportion of DILI in the entire hospitalized population of China was represented by that observed in the 66 centers where DILI capture was complete, we estimated the annual incidence in the general population to be 23.80 per 100,000 persons (95% CI 20.86-26.74). Only hospitalized patients were included in this analysis, so the true incidence is likely to be higher. CONCLUSIONS In a retrospective study to determine the incidence and causes of DILI in mainland China, the annual incidence in the general population was estimated to be 23.80 per 100,000 persons; higher than that reported from Western countries. Traditional Chinese medicines, herbal and dietary supplements, and antituberculosis drugs were the leading causes of DILI in mainland China.

[1]  Neil Kaplowitz,et al.  Idiosyncratic drug hepatotoxicity , 2005, Nature Reviews Drug Discovery.

[2]  H. Takikawa,et al.  Drug‐induced liver injury in Japan: An analysis of 1676 cases between 1997 and 2006 , 2009, Hepatology research : the official journal of the Japan Society of Hepatology.

[3]  Guolin Zhang,et al.  Toxicity of raw and processed roots of Polygonum multiflorum. , 2012, Fitoterapia.

[4]  R. Andrade,et al.  Drug-induced liver injury: an analysis of 461 incidences submitted to the Spanish registry over a 10-year period. , 2005, Gastroenterology.

[5]  T. Teng,et al.  Scientific Approaches to AIDS Prevention and Control in China , 2011, Advances in dental research.

[6]  M. Verma,et al.  The Incidence of Drug- and Herbal and Dietary Supplement-Induced Liver Injury: Preliminary Findings from Gastroenterologist-Based Surveillance in the Population of the State of Delaware , 2017, Drug Safety.

[7]  M. Hartleb,et al.  Drug-induced liver damage -- a three-year study of patients from one gastroenterological department. , 2002, Medical science monitor : international medical journal of experimental and clinical research.

[8]  Fu-Sheng Wang,et al.  Guidelines for the Diagnosis and Management of Herb-Induced Liver Injury , 2018, Chinese Journal of Integrative Medicine.

[9]  Zuhong Lu,et al.  Notification Rate of Tuberculosis among Migrants in China 2005–2014: A Systematic Review and Meta-analysis , 2016, Chinese medical journal.

[10]  C. Hirayama,et al.  Hepatotoxicity of cyclophosphamide in man: pharmacokinetic analysis. , 1988, Research communications in chemical pathology and pharmacology.

[11]  R. Andrade,et al.  Phenotypic characterization of idiosyncratic drug‐induced liver injury: The influence of age and sex , 2009, Hepatology.

[12]  W. Cong,et al.  CSH guidelines for the diagnosis and treatment of drug-induced liver injury , 2017, Hepatology International.

[13]  Yibin Feng,et al.  A Network-Based Pharmacology Study of the Herb-Induced Liver Injury Potential of Traditional Hepatoprotective Chinese Herbal Medicines , 2017, Molecules.

[14]  W. Yeo,et al.  Acute toxicity of adjuvant doxorubicin and cyclophosphamide for early breast cancer -- a retrospective review of Chinese patients and comparison with an historic Western series. , 2002, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[15]  F. D. de Abajo,et al.  Acute and clinically relevant drug-induced liver injury: a population based case-control study. , 2004, British journal of clinical pharmacology.

[16]  R. Fontana,et al.  Causes, clinical features, and outcomes from a prospective study of drug-induced liver injury in the United States. , 2008, Gastroenterology.

[17]  E. Björnsson,et al.  Outcome and prognostic markers in severe drug‐induced liver disease , 2005, Hepatology.

[18]  Jong Sil Lee,et al.  Drug-Induced Liver Injury: Twenty Five Cases of Acute Hepatitis Following Ingestion of Polygonum multiflorum Thunb , 2011, Gut and liver.

[19]  N. Chalasani,et al.  Epidemiology of idiosyncratic drug-induced liver injury. , 2009, Seminars in liver disease.

[20]  Z. Wang,et al.  Non‐genetic risk factors and predicting efficacy for docetaxel–drug‐induced liver injury among metastatic breast cancer patients , 2012, Journal of gastroenterology and hepatology.

[21]  Paul B Watkins,et al.  Drug‐induced liver injury: Summary of a single topic clinical research conference , 2006, Hepatology.

[22]  A. Flahault,et al.  Causality assessment of adverse reactions to drugs--II. An original model for validation of drug causality assessment methods: case reports with positive rechallenge. , 1993, Journal of clinical epidemiology.

[23]  D. J. Kim,et al.  A Prospective Nationwide Study of Drug-Induced Liver Injury in Korea , 2012, The American Journal of Gastroenterology.

[24]  Neil Kaplowitz,et al.  Herb-Induced Liver Injury: A Global Concern , 2018, Chinese Journal of Integrative Medicine.

[25]  S. Itoh,et al.  Liver injuries induced by herbal medicine, Syo-saiko-to (xiao-chai-hu-tang) , 1995, Digestive Diseases and Sciences.

[26]  D. Larrey.  Epidemiology and Individual Susceptibility to Adverse Drug Reactions Affecting the Liver , 2002, Seminars in liver disease.

[27]  S. Olafsson,et al.  Incidence, presentation, and outcomes in patients with drug-induced liver injury in the general population of Iceland. , 2013, Gastroenterology.

[28]  P. Hillon,et al.  Incidence of drug‐induced hepatic injuries: A French population‐based study , 2002, Hepatology.

[29]  G. Danan,et al.  Causality assessment of adverse reactions to drugs--I. A novel method based on the conclusions of international consensus meetings: application to drug-induced liver injuries. , 1993, Journal of clinical epidemiology.

[30]  P. Watkins,et al.  Liver transplantation for acute liver failure from drug induced liver injury in the United States , 2004, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[31]  E. Björnsson,et al.  Drug‐induced liver injury in a Swedish University hospital out‐patient hepatology clinic , 2006, Alimentary pharmacology & therapeutics.

[32]  W. Kremers,et al.  Single-Center Experience With Drug-Induced Liver Injury From India: Causes, Outcome, Prognosis, and Predictors of Mortality , 2010, The American Journal of Gastroenterology.

[33]  R. Fontana,et al.  Causality assessment in drug‐induced liver injury using a structured expert opinion process: Comparison to the Roussel‐Uclaf causality assessment method , 2010, Hepatology.

[34]  William M. Lee,et al.  ACG Clinical Guideline: The Diagnosis and Management of Idiosyncratic Drug-Induced Liver Injury , 2014, The American Journal of Gastroenterology.

[35]  William M. Lee,et al.  Features and Outcomes of 899 Patients With Drug-Induced Liver Injury: The DILIN Prospective Study. , 2015, Gastroenterology.

[36]  S. Marciano,et al.  Imatinib-induced fatal acute liver failure. , 2007, World journal of gastroenterology.

[37]  Li Yang,et al.  Epidemiology of drug-induced liver injury in China: a systematic analysis of the Chinese literature including 21 789 patients , 2013, European journal of gastroenterology & hepatology.

[38]  J. Talwalkar,et al.  Drug-induced liver injury. , 2014, Mayo Clinic proceedings.

[39]  J. Senior,et al.  Drug-related hepatotoxicity. , 2006, The New England journal of medicine.

[40]  E. Björnsson,et al.  Fulminant drug-induced hepatic failure leading to death or liver transplantation in Sweden , 2005, Scandinavian journal of gastroenterology.

[41]  T. Frieden,et al.  Tuberculosis , 1925, The Lancet.

[42]  A. Lu,et al.  Effects of triptolide from Radix Tripterygium wilfordii (Leigongteng) on cartilage cytokines and transcription factor NF-κB: a study on induced arthritis in rats , 2009, Chinese medicine.

[43]  E. Bjornsson.  Review article: drug-induced liver injury in clinical practice , 2010 .

[44]  J. Hou,et al.  Will integrated surveillance systems for vectors and vector-borne diseases be the future of controlling vector-borne diseases? A practical example from China , 2016, Epidemiology and Infection.

[45]  Yan Peng,et al.  Assessment of antibiotic prescription in hospitalised patients at a Chinese university hospital. , 2003, Journal of Infection.

[46]  M. Rawlins,et al.  Accuracy of hepatic adverse drug reaction reporting in one English health region , 1999, BMJ.